About
Opharmic is an innovative medtech company leveraging its expertise in ultrasound to develop proprietary technology platforms for differentiated biomedical applications. Launched in 2017, the company has developed two platform technologies for non-invasive drug delivery and contactless cell stimulation, with a diverse portfolio and pipeline spanning various healthcare sectors. Opharmic's flagship program, MeticTouch, focuses on a groundbreaking ultrasound-based drug delivery device with excellent drug compatibility, designed as a turnkey solution to replace invasive eye injections. In close collaboration with global pharmaceutical partners, MeticTouch offers a revolutionary solution for managing retinal diseases by providing non-invasive treatment options for patients, streamlining workflows for healthcare professionals, and fostering sustainable market growth for pharmaceutical companies. Opharmic's current pipeline encompasses Ophthalmology, Oncology, Regenerative Medicine, and Dermatology, positioning the company as a sustainable innovation engine dedicated to developing novel and high-value solutions that address critical medical unmet needs. Contact Us: [email protected]
Technologies
Keywords
Company Information
-
Employees 15
-
Founded 2016
Location
1 Science Park West Ave, New Territories, Hong Kong
